SCHEMBL4820232

SCHEMBL4820232

[CH](CCc1ccccc1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 1/20 0.39
HTR2A P28223 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
GPR52 Q9Y2T5 2/20 0.39
ACP3 P15309 1/20 0.39
CYP2D6 P10635 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
GRIK1 P39086 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3624305 0.79 TRPA1 (0.43) KCNH2ALDH1A1HPGDALOX15ALOX12
SCHEMBL8710872 0.77 MAOB (0.50) KCNH2HTR2ASMN1; SMN2TAAR1ACP3
SCHEMBL2292003 0.76 SIGMAR1 (0.42) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL8714626 0.72 TDP1 (0.43) ALDH1A1TDP1GPR52CYP2D6SIGMAR1
SCHEMBL18321215 0.72 KCNH2 (0.44) KCNH2ALDH1A1HPGDALOX15ALOX12
SCHEMBL8812260 0.72 TP53 (0.41) KCNH2ALDH1A1HPGDALOX15ALOX12
SCHEMBL7844501 0.71 KCNH2 (0.52) KCNH2ALDH1A1HPGDALOX15ALOX12
SCHEMBL7762166 0.71 GPR52 (0.57) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL205556 0.71 ALDH1A1 (0.52) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL7762164 0.71 GPR52 (0.57) ALDH1A1HPGDALOX15ALOX12CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425580-B2 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2008-09-16 US disclosed
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands ESR1, ESR2, GPER1 KCNH2 2519/4885ALDH1A1 409/4885HPGD 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.